![Joseph Carroll](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Carroll
Comptroller/Controller/Auditor at RENOVACOR, INC.
Joseph Carroll active positions
Companies | Position | Start | End |
---|---|---|---|
RENOVACOR, INC. | Comptroller/Controller/Auditor | 16/06/2022 | - |
Corporate Secretary | 16/06/2022 | - | |
Corporate Officer/Principal | 31/05/2021 | 16/06/2022 |
Career history of Joseph Carroll
Former positions of Joseph Carroll
Companies | Position | Start | End |
---|---|---|---|
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Corporate Officer/Principal | 31/05/2017 | 31/05/2021 |
Training of Joseph Carroll
West Chester University of Pennsylvania | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Corporate Officer/Principal | 2 |
Comptroller/Controller/Auditor | 1 |
Corporate Secretary | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Renovacor, Inc.
![]() Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Stock Market
- Insiders
- Joseph Carroll
- Experience